The global Vascular Embolization Market is estimated to be valued at Us$ 1,509.1 Mn in 2021 and is expected to exhibit a CAGR Of 9.5% over the forecast period 2022 To 2028, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Vascular embolization is a minimally invasive procedure used to treat various vascular conditions such as aneurysms, tumors, arteriovenous malformations, and uterine fibroids. The procedure involves the use of embolic agents to block or reduce blood flow to the targeted area, thereby eliminating the abnormality. Vascular embolization offers several advantages over traditional surgical procedures, including shorter hospital stay, reduced risk of complications, and faster recovery. The increasing prevalence of cardiovascular diseases, along with the growing demand for minimally invasive procedures, is driving the adoption of vascular embolization products.
Market key trends:
One key trend in the vascular embolization market is the development of advanced embolic agents. Traditional embolic agents such as gelatin sponge and polyvinyl alcohol have limitations in terms of stability, delivery, and efficacy. To overcome these limitations, companies are focusing on the development of next-generation embolic agents, including microspheres, liquid embolics, and bioabsorbable materials. These advanced embolic agents offer improved control, precise delivery, and better clinical outcomes. The development of such innovative products is expected to drive the growth of the vascular embolization market in the coming years.
Note: The report also provides information about key players in the market, including Shape Memory Medical Inc., Terumo Corp, Penumbra Inc., Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation, among others. However, this information is not included in the report overview and market key trends.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the vascular embolization market is low to moderate. Although the market requires specialized knowledge and technology, the high growth potential and profitability of the market may attract new players. Additionally, the regulatory barriers and the need for extensive research and development can act as a deterrent for new entrants.
Bargaining power of buyers: The bargaining power of buyers in the vascular embolization market is moderate. Buyers such as hospitals and healthcare providers have the power to negotiate prices and demand high-quality products. However, the limited number of suppliers and the critical nature of the products can limit their bargaining power to some extent.
Bargaining power of suppliers: The bargaining power of suppliers in the vascular embolization market is moderate to high. Suppliers of medical devices and materials have the advantage of providing essential products to the market. As a result, they can negotiate higher prices and favorable terms with manufacturers. Moreover, the suppliers' expertise and technological advancements can further increase their bargaining power.
Threat of new substitutes: The threat of new substitutes in the vascular embolization market is low. Vascular embolization procedures are highly specialized and effective in treating various medical conditions. The lack of equally effective alternatives makes it difficult for substitutes to enter the market.
Competitive rivalry: The competitive rivalry in the vascular embolization market is intense. Key players in the market are continuously striving to innovate and develop advanced solutions to gain a competitive edge. The presence of well-established companies and the rapid growth of the market contribute to the high level of competition.
Key Takeaways
The global Vascular Embolization Market is expected to witness high growth, exhibiting a CAGR of 9.5% over the forecast period. This growth can be attributed to the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, which require vascular embolization procedures for effective treatment. The rising geriatric population and advancements in technology and medical devices also contribute to market growth.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the vascular embolization market. This can be attributed to the high prevalence of chronic diseases, well-established healthcare infrastructure, and extensive research and development activities in the region. Additionally, the favorable reimbursement policies and increased adoption of advanced medical technologies further support market growth in North America.
Key players operating in the vascular embolization market include Shape Memory Medical Inc., Terumo Corp, Penumbra Inc., Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation. These key players are focused on research and development activities, mergers and acquisitions, and collaborations to strengthen their market position and gain a competitive advantage.
In conclusion, the vascular embolization market is poised for significant growth due to the increasing prevalence of chronic diseases and advancements in medical technology. However, the market is highly competitive, and key players need to innovate and invest in research and development to stay ahead. Additionally, the market dynamics, such as the bargaining power of buyers and suppliers, should be carefully managed to ensure sustained growth in the industry.
Read More : www.newsstatix.com/vascular-embolization-market-is-estimated-to-witness-high-growth-owing-to-growing-demand-for-minimally-invasive-procedures/
